Rapid Micro Biosystems (RPID) EPS (Basic) (2020 - 2026)
Rapid Micro Biosystems (RPID) reported EPS (Basic) of -$0.31 for Q1 2026, down 22.72% on a YoY basis from -$0.41 in Q1 2025, and down 12.33% sequentially from -$0.28 in Q4 2025.
Rapid Micro Biosystems (RPID) EPS (Basic) (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of EPS (Basic) data on file, last reported at -$0.31 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 22.72% year-over-year to -$0.31; the trailing twelve-month figure through Mar 2026 stood at -$1.1 (down 8.29% YoY), and the FY2025 full-year result was -$1.05, up 1.98% from the prior year.
- EPS (Basic) declined to -$0.31 in Q1 2026, from -$0.28 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.22 in Q4 2024 to a low of -$0.39 in Q4 2022.
- A 5-year average of -$0.3 and a median of -$0.31 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 99.07% in 2022 and slipped 26.09% in 2025, its largest moves.
- Tracing RPID's EPS (Basic) over 5 years: stood at -$0.39 in 2022, then soared by 32.97% to -$0.26 in 2023, then increased by 14.58% to -$0.22 in 2024, then decreased by 26.09% to -$0.28 in 2025, then retreated by 12.33% to -$0.31 in 2026.
- Business Quant data shows RPID's EPS (Basic) at -$0.31 in Q1 2026, -$0.28 in Q4 2025, and -$0.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | -0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.31 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.31 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -0.31 |
| Jun 30, 2023 | -0.33 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.31 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.74 |
| Sep 30, 2021 | -0.71 |
| Jun 30, 2021 | -20.01 |